Seventeen patients transplanted with hematopoietic cells to correct severe T lymphocyte immunodeficiency resulting from complete DiGeorge anomaly were identified worldwide, and retrospective data were obtained using a questionnaire-based survey. Patients were treated at a median age of 5 months (range, 2-53 months) between 1995 and 2006. Bone marrow was used in 11 procedures in 9 cases: 6 from matched unrelated donors, 4 from human leukocyte antigen (HLA)-identical siblings, and one haploidentical parent with T-cell depletion. Unmobilized peripheral blood was used in 8 cases: 5 from HLA-identical siblings, one from a matched unrelated donor, one from an HLA-identical parent, and one unrelated matched cord blood. Conditioning was used in 5 patients and graft-versus-host disease prophylaxis in 11 patients. Significant graft-versus-host disease occurred in 9 patients, becoming chronic in 3. Median length of follow-up was 13 months, with transplantation from HLA-matched sibling showing the best results. Median survival among deceased patients (10 patients) was 7 months after transplantation (range, 2-18 months). The overall survival rate was 41%, with a median follow-up of 5.8 years (range, 4-11.5 years). Among survivors, median CD3 and CD4 counts were 806 (range, 644-1224) and 348 (range, 225-782) cells/mm(3), respectively, CD4(+)/CD45RA(+) cells remained very low, whereas mitogen responses were normalized.

Department of Pediatric Hematology and Oncology University Hospital Motol and 2nd Medical School Charles University Prague Czech Republic

Zobrazit více v PubMed

Markert ML, Devlin BH, Alexieff MJ, et al. Review of 54 patients with complete DiGeorge anomaly enrolled in protocols for thymus transplantation: outcome of 44 consecutive transplants. Blood. 2007;109(10):4539–4547. PubMed PMC

Gosseye S, Golaire MC, Verellen G, Van Lierde M, Claus D. Association of bilateral renal agenesis and Di George syndrome in an infant of a diabetic mother. Helv Paediatr Acta. 1982;37(5):471–474. PubMed

Wang R, Martinez-Frias ML, Graham JM., Jr Infants of diabetic mothers are at increased risk for the oculo-auriculo-vertebral sequence: a case-based and case-control approach. J Pediatr. 2002;141(5):611–617. PubMed

Oskarsdottir S, Persson C, Eriksson BO, Fasth A. Presenting phenotype in 100 children with the 22q11 deletion syndrome. Eur J Pediatr. 2005;164(3):146–153. PubMed

Markert ML, Alexieff MJ, Li J, et al. Complete DiGeorge syndrome: development of rash, lymphadenopathy, and oligoclonal T cells in 5 cases. J Allergy Clin Immunol. 2004;113(4):734–741. PubMed

Gennery AR, Slatter MA, Rice J, et al. Mutations in CHD7 in patients with CHARGE syndrome cause T-B + natural killer cell + severe combined immune deficiency and may cause Omenn-like syndrome. Clin Exp Immunol. 2008;153(1):75–80. PubMed PMC

Borzy MS, Ridgway D, Noya FJ, Shearer WT. Successful bone marrow transplantation with split lymphoid chimerism in DiGeorge syndrome. J Clin Immunol. 1989;9(5):386–392. PubMed

Matsumoto T, Amamoto N, Kondoh T, Nakayama M, Takayanagi T, Tsuji Y. Complete-type DiGeorge syndrome treated by bone marrow transplantation. Bone Marrow Transplant. 1998;22(9):927–930. PubMed

Goldsobel AB, Haas A, Stiehm ER. Bone marrow transplantation in DiGeorge syndrome. J Pediatr. 1987;111(1):40–44. PubMed

Janda A, Sedlacek P, Mejstrikova E, et al. Unrelated partially matched lymphocyte infusions in a patient with complete DiGeorge/CHARGE syndrome. Pediatr Transplant. 2007;11(4):441–447. PubMed

Al-Tamemi S, Mazer B, Mitchell D, et al. Complete DiGeorge anomaly in the absence of neonatal hypocalcemia and velofacial and cardiac defects. Pediatrics. 2005;116(3):e457–e460. PubMed

Ohtsuka Y, Shimizu T, Nishizawa K, et al. Successful engraftment and decrease of cytomegalovirus load after cord blood stem cell transplantation in a patient with DiGeorge syndrome. Eur J Pediatr. 2004;163(12):747–748. PubMed

Bowers DC, Lederman HM, Sicherer SH, Winkelstein JA, Chen AR. Immune constitution of complete DiGeorge anomaly by transplantation of unmobilised blood mononuclear cells. Lancet. 1998;352(9145):1983–1984. PubMed

Bensoussan D, Le Deist F, Latger-Cannard V, et al. T-cell immune constitution after peripheral blood mononuclear cell transplantation in complete DiGeorge syndrome. Br J Haematol. 2002;117(4):899–906. PubMed

Daguindau N, Decot V, Nzietchueng R, et al. Immune constitution monitoring after PBMC transplantation in complete DiGeorge syndrome: an eight-year follow-up. Clin Immunol. 2008;128(2):164–171. PubMed

Hoenig M, Schulz A, Schuetz C, Debatin K-M, Friedrich W. Treatment of complete DiGeorge syndrome by repeat transfusions of blood lymphocytes from an HLA-identical sibling donor. ASH Annual Meeting Abstracts. 2004;104(11):1332.

Mayumi M, Kimata H, Suehiro Y, et al. DiGeorge syndrome with hypogammaglobulinaemia: a patient with excess suppressor T cell activity treated with fetal thymus transplantation. Eur J Pediatr. 1989;148(6):518–522. PubMed

Thong YH, Robertson EF, Rischbieth HG, et al. Successful restoration of immunity in the DiGeorge syndrome with fetal thymic epithelial transplant. Arch Dis Child. 1978;53(7):580–584. PubMed PMC

Markert ML, Devlin BH, Chinn IK, McCarthy EA, Li YJ. Factors affecting success of thymus transplantation for complete DiGeorge anomaly. Am J Transplant. 2008;8(8):1729–1736. PubMed PMC

Hoover-Fong J, Savage WJ, Lisi E, et al. Congenital T cell deficiency in a patient with CHARGE syndrome. J Pediatr. 2009;154(1):140–142. PubMed PMC

Markert ML. Treatment of infants with complete DiGeorge anomaly. J Allergy Clin Immunol. 2008;121(4):1063. author reply 1063–1064. PubMed

Land MH, Garcia-Lloret MI, Borzy MS, et al. Long-term results of bone marrow transplantation in complete DiGeorge syndrome. J Allergy Clin Immunol. 2007;120(4):908–915. PubMed

Buckley RH, Schiff SE, Schiff RI, et al. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med. 1999;340(7):508–516. PubMed

Grunebaum E, Mazzolari E, Porta F, et al. Bone marrow transplantation for severe combined immune deficiency. JAMA. 2006;295(5):508–518. PubMed

Antoine C, Muller S, Cant A, et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99. Lancet. 2003;361(9357):553–560. PubMed

Neven B, Leroy S, Decaluwe H, et al. Long-term outcome after hematopoietic stem cell transplantation of a single-center cohort of 90 patients with severe combined immunodeficiency. Blood. 2009;113(17):4114–4124. PubMed

Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency